» Authors » K Dickinson

K Dickinson

Explore the profile of K Dickinson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 478
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rizzuto I, Nicholson R, Dickinson K, Juang H, MacNab W, Rufford B
Gynecol Oncol Rep . 2019 Apr; 28:101-103. PMID: 30993161
We report a 29-year old nulliparous woman diagnosed with a grade 1 endometrioid adenocarcinoma of the endometrium arising from an atypical polypoid adenomyoma, while being investigated for a suspected threatened...
2.
Thokala P, Simpson E, Tappenden P, Stevens J, Dickinson K, Ryder S, et al.
Pharmacoeconomics . 2016 Feb; 34(8):741-50. PMID: 26892974
The National Institute for Health and Care Excellence (NICE) invited Gilead, the company manufacturing ledipasvir-sofosbuvir (LDV/SOF), to submit evidence for the clinical effectiveness and cost effectiveness of LDV/SOF for treating...
3.
Mokhtarani M, Diaz G, Rhead W, Berry S, Lichter-Konecki U, Feigenbaum A, et al.
Mol Genet Metab . 2013 Oct; 110(4):446-53. PMID: 24144944
Background: Phenylacetic acid (PAA) is the active moiety in sodium phenylbutyrate (NaPBA) and glycerol phenylbutyrate (GPB, HPN-100). Both are approved for treatment of urea cycle disorders (UCDs) - rare genetic...
4.
Monteleone J, Mokhtarani M, Diaz G, Rhead W, Lichter-Konecki U, Berry S, et al.
J Clin Pharmacol . 2013 Jun; 53(7):699-710. PMID: 23775211
Sodium phenylbutyrate and glycerol phenylbutyrate mediate waste nitrogen excretion in the form of urinary phenylacetylglutamine (PAGN) in patients with urea cycle disorders (UCDs); rare genetic disorders characterized by impaired urea...
5.
Butterfield B, Cavieres L, Callaway R, Cook B, Kikvidze Z, Lortie C, et al.
Ecol Lett . 2013 Jan; 16(4):478-86. PMID: 23346919
Biotic interactions can shape phylogenetic community structure (PCS). However, we do not know how the asymmetric effects of foundation species on communities extend to effects on PCS. We assessed PCS...
6.
Mokhtarani M, Diaz G, Rhead W, Lichter-Konecki U, Bartley J, Feigenbaum A, et al.
Mol Genet Metab . 2012 Sep; 107(3):308-14. PMID: 22958974
Unlabelled: We have analyzed pharmacokinetic data for glycerol phenylbutyrate (also GT4P or HPN-100) and sodium phenylbutyrate with respect to possible dosing biomarkers in patients with urea cycle disorders (UCD). Study...
7.
Lichter-Konecki U, Diaz G, Merritt 2nd J, Feigenbaum A, Jomphe C, Marier J, et al.
Mol Genet Metab . 2011 May; 103(4):323-9. PMID: 21612962
Unlabelled: Twenty four hour ammonia profiles and correlates of drug effect were examined in a phase 2 comparison of sodium phenylbutyrate (NaPBA) and glycerol phenylbutyrate (GPB or HPN-100), an investigational...
8.
PROCTER I, Dickinson K
Am J Obstet Gynecol . 2010 Mar; 53(1):65-74. PMID: 20283740
No abstract available.
9.
Fell M, Anjum N, Dickinson K, Marshall K, Peltola L, Vickers S, et al.
Psychopharmacology (Berl) . 2007 Jun; 194(2):221-31. PMID: 17581744
Introduction: Treatment with some antipsychotic drugs may result in excessive body weight gain which can have detrimental effects on patient compliance, morbidity and mortality. The aim of the present study...
10.
Troxler M, Dickinson K, Homer-Vanniasinkam S
Br J Surg . 2007 May; 94(6):674-82. PMID: 17514662
Background: Platelets have roles other than haemostasis and many are relevant to surgical practice. This review examines both the pathophysiology of platelets in haemostasis and thrombosis, and other roles of...